Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Clin Lung Cancer. 2020 Jul 3;21(6):553–561.e1. doi: 10.1016/j.cllc.2020.06.025

Table 3.

Best Response on Pemetrexed and Observation Arm

Best Response Pemetrexed
(N=27)
Observa6on
(N=21)
Total
(N=48)
 Complete 1 (3.7%) 0 (0%) 1 (2.1%)
 Partial 2 (7.4%) 0 (0%) 2 (4.2%)
 Stable 12 (44.4%) 14 (66.6%) 26 (54.2%)
 Progression 12 (44.4%) 6 (28.6%) 18 (37.5%)
 Non CR/ Non PD 0 (0.0%) 1 (4.8%) 1 (2.1%)
Response Rate (95% CI) * 11.1 (2.4, 29.2) 0 (0, 0) 6.3 (1.3, 17.2)

One pa6ent’s tumor response is unavailable due to withdrawal of consent for follow-up

*

Fisher’s exact test on response rate between two arms, two-sided: p =0.2460

Abbreviations: Non CR = non complete response; non PD = non progressive disease